Jason Hou, MD, on Newer and Emerging Therapeutic Targets
09/25/2020
Dr Hou discusses his presentation on new therapeutic agents in development for treatment of IBD, from the September 26 virtual Advances in Inflammatory Bowel Disease regional meeting.
Additional Resources:
For more information about AIBD 2020 and to register for the AIBD Annual Meeting in December, visit https://www.advancesinibd.com
Jason Hou, MD, is an associate professor of medicine and gastroenterologist from Baylor College of Medicine in Houston, Texas.
